Middle-aged men who eat higher amounts of protein are associated with a slightly elevated risk for heart failure (HF) than those who eat less protein, according to a new study published in Circulation: Heart Failure on May 29. There is a limited amount of information regarding how diets high in protein impact men’s HF risk.

Heart failure patients who were given instructions on how to use a Nintendo Wii device—which incorporates physical activity into video gaming—improved their exercise capacity and quality of life more than counterparts who were simply advised to exercise 30 minutes per day.

MILFORD, Mass. — May 29, 2018 — RenalGuard Solutions™, Inc., a medical device company focused on innovative fluid management technologies for the cardiac and vascular markets, today announced new clinical study results demonstrating the feasibility of using RenalGuard®-Guided Diuretic Therapy to optimize fluid management in Acute Decompensated Heart Failure (ADHF) patients while alleviating related symptoms.

The debate over the ideal blood glucose target for type 2 diabetics continued this week in the Annals of Internal Medicine, with a group of researchers defending the current recommendations of below 7 percent.

Pfizer gave more than $10 million to a charity for heart patients while dramatically increasing the price of one of its antiarrhythmic drugs, deflecting costs from patients and leaving Medicare with a bigger bill, the U.S. Justice Department said in a May 24 settlement statement.

Total adherence to the 2017 hypertension guidelines would result in about 330,000 fewer deaths each year in the U.S., according to a study published May 23 in JAMA Cardiology.

Individuals with a combination of vascular risk factors and higher levels of beta-amyloid protein in the brain may be on a speedier path of cognitive decline, suggests a study published May 21 in JAMA Neurology.

DUBLIN — May 24, 2018 — Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2018, which ended April 27.

Philips has reached an agreement with the governments of Ethiopia and the Netherlands to build a €40 million cardiac care facility—the first such specialty hospital in the East African country.

Once more expensive P2Y12 inhibitors hit the U.S. market, the percentage of patients not filling prescriptions for any P2Y12 inhibitor after percutaneous coronary intervention (PCI) increased from 6 percent to 19 percent, researchers reported in JAMA Internal Medicine.